Welcome to our dedicated page for Cno Finl Group SEC filings (Ticker: CNO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The CNO Financial Group, Inc. (NYSE: CNO) SEC filings page on Stock Titan brings together the company’s regulatory disclosures from the U.S. Securities and Exchange Commission, along with AI-powered summaries to help interpret them. As a life and health insurer and financial services provider focused on middle-income America, CNO uses its filings to present detailed information on its insurance products, capital position and operating performance.
Investors can review CNO’s current reports on Form 8-K, which the company uses to furnish quarterly earnings press releases, quarterly financial supplements and additional financial and operating data. These filings commonly include metrics such as net income, net operating income, income from insurance products across annuity, health and life lines, fee income, investment income not allocated to product lines, and measures like book value per share and operating return on equity.
Over time, CNO’s SEC filings also provide insight into capital management and structure, including common stock dividends, share repurchase activity, reinsurance transactions with its wholly owned Bermuda reinsurance company, and technology modernization initiatives such as the TechMod project. Filings may describe changes in business mix, such as the decision to exit the fee services side of the Worksite Division to focus on core insurance offerings.
On Stock Titan, AI-generated highlights help explain the key points in lengthy documents, so users can quickly understand what each filing means for CNO’s insurance operations, investment portfolio and shareholders. Real-time updates from EDGAR ensure that new 8-Ks and other forms appear promptly, while tools for viewing insider-related information, capital actions and recurring reporting patterns make it easier to analyze CNO’s regulatory history.
CNO Financial Group, Inc. reported an insider equity transaction by its President, Worksite Division. On 01/02/2026, the officer surrendered 1,375 shares of common stock to the company at $42.20 per share to cover required tax withholding on vested restricted stock units. This was not an open-market sale but a share surrender back to the issuer for tax purposes. After this transaction, the officer directly beneficially owned 38,980 shares of CNO common stock.
CNO Financial Group, Inc. reported an amended insider transaction for its Chief Actuary on a Form 4/A. On 01/02/2025, the officer surrendered 773 shares of common stock at $37.14 per share. The shares were returned to the company to cover required tax withholding on vested restricted stock units, so this was not an open‑market sale. After this withholding transaction, the officer beneficially owned 61,348 shares of CNO common stock. The amendment states it corrects both the number of securities disposed of in this transaction and the amount of securities beneficially owned following the transaction.
CNO Financial Group, Inc. reported that its Chief Executive Officer and director, through personal holdings, sold common stock in a planned insider transaction. On 01/02/2026, the reporting person sold 31,430 shares of CNO common stock at a weighted average price of $41.9866 per share, with individual sale prices ranging from $41.635 to $42.425. The sale was executed under a Rule 10b5-1 trading plan adopted on August 21, 2025.
Following this transaction, the reporting person beneficially owns 195,926 shares directly and an additional 635,471 shares indirectly through the Gary C. Bhojwani Revocable Trust. This filing provides transparency into the CEO’s equity transactions and current ownership stake in CNO Financial Group.
CNO Financial filed a Form 144 notice covering a planned sale of 31,430 shares of its common stock by insider Gary Bhojwani through Morgan Stanley Smith Barney LLC on or about 01/02/2026 on the NYSE. The filing lists an aggregate market value of $1,319,641.98 for these shares and notes that 95,353,512 common shares were outstanding. The securities to be sold were acquired as restricted stock and performance shares from the issuer on 03/25/2025 and 02/14/2023, respectively. Over the past three months, the same seller disposed of 31,430 common shares for gross proceeds of $1,256,222.53.
CNO Financial Group’s Chief Marketing Officer, who is an officer of the company, reported two sales of common stock. On December 15, 2025, the officer sold 6,051 shares at $42.25 and 3,232 shares at $43.25. After these transactions, the officer beneficially owned 73,932 shares of CNO common stock. The shares were sold pursuant to a Rule 10b5-1 trading plan adopted on June 9, 2025.
CNO common stock is the subject of a planned Rule 144 sale of 9283 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services, with an aggregate market value of 395438.75. The shares are listed on the NYSE, and 95353512 shares of this class were outstanding, with the approximate sale date noted as 12/15/2025.
The seller acquired 3232 performance shares from the issuer on 02/11/2025 and 6051 restricted shares from the issuer on 03/25/2025, with the nature of payment listed as Not Applicable for both awards. The notice also states that the person for whose account the securities are to be sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.
CNO Financial Group, Inc. reported a routine insider transaction by its Chief Operations Officer. On 12/05/2025, 135 shares of common stock were surrendered back to the company at a price of $40.18 per share. The filing explains that these shares were withheld to cover required tax obligations on previously granted restricted stock units, a common administrative step when equity awards vest.
After this tax withholding transaction, the officer continues to beneficially own 30,709 shares of CNO Financial Group common stock in direct form. This event does not reflect an open‑market sale or purchase, but rather an automatic share surrender to satisfy tax requirements tied to equity compensation.
CNO Financial Group reported an insider transaction by its Chief Investment Officer. On 12/05/2025, the officer surrendered 584 shares of CNO common stock to the company at a price of $40.18 per share. These shares were withheld to cover required tax obligations on previously granted restricted stock units, rather than being an open-market sale.
After this tax-related share surrender, the officer directly beneficially owns 670,958 shares of CNO common stock. The filing is a routine Form 4 disclosure reflecting equity award tax withholding for a senior executive.
CNO Financial Group, Inc. disclosed that its Chief Human Resources Officer, Yvonne K. Franzese, surrendered 475 shares of common stock on 12/05/2025. The shares were returned to the company at a price of $40.18 per share to satisfy required tax withholding on previously granted restricted stock units. After this administrative, tax-related transaction, she directly holds 21,142 CNO shares and indirectly holds 78,279 shares through the Yvonne K. Franzese Revocable Trust. The filing reflects a routine Form 4 insider ownership update rather than an open-market trade.
CNO Financial Group (CNO)11/24/2025, the officer sold 3,000 shares of common stock at a price of $41 per share, according to a Form 4 filing. After this transaction, the officer directly owned 21,617 shares and indirectly owned 78,279 shares through the Yvonne K. Franzese Revocable Trust.
The filing notes that the shares were sold under a pre-arranged Rule 10b5-1 trading plan that was adopted on August 20, 2025. Such plans allow insiders to sell shares according to preset instructions, helping separate personal trading decisions from nonpublic company information.